CLINICAL TRIALS PROFILE FOR PEGAPTANIB SODIUM
✉ Email this page to a colleague
All Clinical Trials for Pegaptanib Sodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00040313 ↗ | Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula | Completed | Eyetech Pharmaceuticals | Phase 2 | 2002-10-01 | The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and effective in slowing the leakage of fluid within the retina and thereby stabilizing or improving vision when compared to placebo injections. A total of 176 patients will be enrolled |
NCT00087763 ↗ | Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) | Completed | Pfizer | Phase 2 | 2004-03-01 | The purpose of this study is to determine if Macugen™ reduces foveal thickness and improves vision in patients with wet AMD. |
NCT00087763 ↗ | Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) | Completed | Eyetech Pharmaceuticals | Phase 2 | 2004-03-01 | The purpose of this study is to determine if Macugen™ reduces foveal thickness and improves vision in patients with wet AMD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Pegaptanib Sodium
Condition Name
Clinical Trial Locations for Pegaptanib Sodium
Trials by Country
Clinical Trial Progress for Pegaptanib Sodium
Clinical Trial Phase
Clinical Trial Sponsors for Pegaptanib Sodium
Sponsor Name